Literature DB >> 2794791

Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels.

R B Verdery1, D F Benham, H L Baldwin, A P Goldberg, A V Nichols.   

Abstract

This report describes development of a computerized method for analyzing polyacrylamide gradient gels of high density lipoproteins (HDL) by Gaussian summation, a simple technique to obtain standardized measurements of size and amount of HDL subfractions. Conditions for reproducibility and ranges of linearity were established. By Gaussian summation analysis, five or six HDL subfractions could be found in the plasma of most normolipidemic people. The relationship of staining intensity to cholesterol level was determined for Coomassie Blue R-250, permitting determination of the cholesterol levels in the individual subfractions, with standard errors of repeated measurements of 2% or less of the total HDL area, and accuracy, limited by the standard error of the chromogenicity, of 1-2 mg/dl for the least abundant fractions and 3-4 mg/dl for the most abundant subfractions. Levels of HDL2b measured by this method were statistically the same as levels of HDL2 measured by dextran sulfate-Mg2+ precipitation. Gaussian summation analysis of gradient gels was used to measure HDL subfraction cholesterol levels in subjects from the Baltimore Longitudinal Study on Aging to obtain normative levels for men and women for the major HDL subfractions. Comparisons of these levels with each other and with triglyceride and cholesterol levels showed that triglyceride levels were inversely correlated with levels of HDL2a and HDL2b, cholesterol levels were directly correlated with levels of HDL3b and HDL3a, and that HDL3b levels were inversely correlated with levels of both HDL2a and HDL2b.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794791

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Human pedigree-based quantitative-trait-locus mapping: localization of two genes influencing HDL-cholesterol metabolism.

Authors:  L Almasy; J E Hixson; D L Rainwater; S Cole; J T Williams; M C Mahaney; J L VandeBerg; M P Stern; J W MacCluer; J Blangero
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

2.  The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors:  Richard E Morton; Yan Liu
Journal:  J Lipid Res       Date:  2020-06-26       Impact factor: 5.922

3.  In silico modeling of the dynamics of low density lipoprotein composition via a single plasma sample.

Authors:  Martin Jansen; Peter Pfaffelhuber; Michael M Hoffmann; Gerhard Puetz; Karl Winkler
Journal:  J Lipid Res       Date:  2016-03-25       Impact factor: 5.922

4.  Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.

Authors:  T Chajek-Shaul; T Hayek; A Walsh; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

5.  Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.

Authors:  T Hayek; Y Ito; N Azrolan; R B Verdery; K Aalto-Setälä; A Walsh; J L Breslow
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and Podocytes.

Authors:  Nidhi Gupta; Xinhua Wang; Xiaohui Wen; Paul Moran; Maciej Paluch; Philip E Hass; Amy Heidersbach; Benjamin Haley; Daniel Kirchhofer; Randall J Brezski; Andrew S Peterson; Suzie J Scales
Journal:  J Am Soc Nephrol       Date:  2020-08-06       Impact factor: 10.121

7.  Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.

Authors:  T Hayek; N Azrolan; R B Verdery; A Walsh; T Chajek-Shaul; L B Agellon; A R Tall; J L Breslow
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level.

Authors:  Timo Paavola; Sanna Kuusisto; Matti Jauhiainen; Sakari Kakko; Tiia Kangas-Kontio; Jari Metso; Pasi Soininen; Mika Ala-Korpela; Risto Bloigu; Minna L Hannuksela; Markku J Savolainen; Tuire Salonurmi
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.